Skip to content
Pharma Observatory a Scientist.com platform

Organization (Other)

University of Child Health Sciences and Children's Hospital, Lahore

ClinicalTrials.gov lists University of Child Health Sciences and Children's Hospital, Lahore as lead sponsor of 11 trials. It has 11 active development programs and 5 approved assets.

Other
Email me this page as a PDF

Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Disease areas Disease areas 17 Trials by start year as sponsor or collaborator Trials by start year as sponsor or collaborator 3 Active development programs Active development programs 11 Approved assets Approved assets 5 Journals published in Journals published in 15 Latest dated events Latest dated events 15 Disease areas Disease areas 17 Trials by start year as sponsor or collaborator Trials by start year as sponsor or collaborator 3 Active development programs Active development programs 11 Approved assets Approved assets 5 Journals published in Journals published in 15 Latest dated events Latest dated events 15

Rows recorded per section

18 sections measured, none recorded

This page covers University of Child Health Sciences and Children's Hospital, Lahore: 11 lead-sponsored trials and 0 legal-entity registrations.

Get the University of Child Health Sciences and Children's Hospital, Lahore report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Disease areas (17)

Shown in this order: most trials first.

Disease areas
Disease area Trials
Anemia 1
Anemia, Iron-Deficiency 1
Anorectal Malformations 1
Arthritis, Juvenile 1
Biliary Atresia 1

Showing 5 of 17 disease areas.

Start your 14-day trial Email me all 17 disease areas as a PDF

Trials by start year as sponsor or collaborator (3)

Shown in this order: most recent first. 2026 is partial: trials registered with a 2026 start date so far, not a full year.

Trials by start year as sponsor or collaborator
Year Trials started
2026 (partial year) 4
2025 9
2024 2

No forecast is made for this organization: it averages 3.0 trial starts a year over the five years to September, under the 5 a year the method needs.

Recruitment duration, a model prediction: 3 trials still running at the 2026-10-09 snapshot, fewer than the 5 needed for a median. Source: ClinicalTrials.gov / AACT (CTTI), public domain.

The series also counts trials where the organization is a collaborator; the lead-sponsor trial count does not.

Active development programs (11)

Shown in this order: max phase, then active trials.

Active development programs
Drug Disease area Max phase Trials
Injection, Etanercept, 25 Mg (Code May Be Used for Medicare When Drug Administered Under the Direct Supervision of A Physician, Not for Use When Drug is Self Administered) Arthritis, Juvenile Phase 3 1
Ferrous Fumarate Anemia, Iron-Deficiency Phase 3 1
Ferrous Fumarate Anemia Phase 3 1
Ferrous Fumarate Iron Deficiencies Phase 3 1
MELATONIN Hypoxia Phase 2 1

Showing 5 of 11 active programs.

Start your 14-day trial Email me all 11 active programs as a PDF

Approved assets (5)

Shown in this order: max phase first.

Approved assets
Drug Trials
Ferrous Fumarate 1
MgSO4 1
Metronidazole 1
MELATONIN 1
Nitazoxanide 1

Journals published in (15)

Shown in this order: most published in first.

Journals published in
Journal Publications
ASN neuro 1
Antioxidants (Basel, Switzerland) 1
Clinics in perinatology 1
Cureus 1
European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society 1

Showing 5 of 15 journals.

Start your 14-day trial Email me all 15 journals as a PDF

Latest dated events (15)

Shown in this order: newest first.

Latest dated events
Date Event Source
2026-09 Trial started Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI))
2026-07-01 Trial started Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI))
2026-05-03 Trial started Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI))
2026-01-27 Trial started Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI))
2025-12-10 Trial started Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI))

Showing 5 of 15 events.

Start your 14-day trial Email me all 15 events as a PDF

Not on this page

Checked, with nothing recorded for this organization: companies grouped under this page, related companies not grouped here, sponsor delivery record, us granted patents, sec-reported annual financials, financing and grant events, fda warning letters, fda untitled letters, fda inspection record, fda recalls, fda import refusals, manufacturing and distribution sites, climate targets, as filed, workforce and board diversity, as filed, organization relationships, clia clinical laboratory certificates, biomarker capability evidence, and biomarkers this organization publishes on.